Neuralink, co-founded by Elon Musk, is launching its first clinical trial to implant brain chips in humans, aiming to help people with paralysis control devices using their thoughts.
Image Credit - Instagram
The trial, named PRIME (Precise Robotically Implanted Brain-Computer Interface), will evaluate the safety of the implant,
Image Credit - Instagram
surgical robot, and brain-computer interface software over six years.
Image Credit - Instagram
Eligible participants will have the N1 Implant placed in the region of the brain controlling movement intention by the R1 Robot.
Image Credit - Instagram
The N1 Implant records and transmits brain signals wirelessly to an app, allowing participants to control a computer or device through thought alone.
Image Credit - Instagram
Neuralink's goal is to improve the lives of tetraplegic or quadriplegic individuals, enabling them to use computers, phones, and devices with their brain activity.
Image Credit - Instagram
The implant consists of multiple chips, a wireless battery, and electronics sealed within a device about the size of a large coin.
Image Credit - Instagram
Ultra-thin threads extend from the implant into the brain, transmitting signals to a brain-computer interface via Bluetooth.
Image Credit - Instagram
The study will span six years, including nearly two dozen follow-up visits to monitor participants' progress and ensure the BCI functions as intended.
Image Credit - Instagram
Participants will undergo nine home and in-person clinic visits in the first year and a half, followed by two research sessions per week in one-hour increments during the study.
Image Credit - Instagram
Neuralink will provide follow-up care for 3.5 years, and participants will receive compensation only for study-related costs,
Image Credit - Instagram
such as transportation expenses. Eligibility can be determined by filling out an application on Neuralink's website.
Image Credit - Instagram